
1094-61-7 Nicotinamide Mononucleotide Bulk Powder Pure NMN
Phone Number : 86-15209233790
WhatsApp : +8615209233790
Minimum Order Quantity : | 1kg, 25kg/drum, sample is available | Price : | Negotiable |
---|---|---|---|
Packaging Details : | Vacuum Aluminum Foil Bag; Fiber Drum for 25kg with inside double layer food grade poly bag | Delivery Time : | 5-7 working days |
Payment Terms : | T/T, Western Union, Pay Pal, Alibaba Assurance Account | Supply Ability : | 250kg/month |
Place of Origin: | China | Brand Name: | Xi'an Le-Nutra |
---|---|---|---|
Certification: | FDA,ISO9001,HACCP,HALAL,KOSHER etc | Model Number: | Pure NMN Powder |
Detail Information |
|||
Product Name: | Beta Nicotinamide Mononucleotide | CAS: | 1094-61-7 |
---|---|---|---|
Molecular Formula: | C11H15N2O8P | Molecular Weight: | 334.22 |
Mainly Used: | Forebody Of NAD+, Anti Aging | Application: | Food Supplements; Pharmaceutical Use; Cosmetic |
Grade: | Food Grade, Pharmaceutical Grade | Appearance: | White Powder |
Highlight: | High Purity NMN Supplement Powder,Anti Aging NMN Supplement Powder,High Purity anti aging nmn |
Product Description
High Purity NMN Supplement Powder Factory Price Anti Aging
Product Introduction of NMN Supplement Powder
NMN Supplement Powder - "C11H15N2O8P", a molecule that occurs naturally in all forms of life. At the molecular level, it is a ribonucleic acid, the basic structural unit of the nucleic acid RNA. Structurally, the molecule consists of a nicotinamide group, a ribose and a phosphate group.NMN is a direct precursor of the essential molecule nicotinamide adenine dinucleotide (NAD+) and is considered to be a key component in increasing intracellular NAD+ levels.
Product Function of NMN Supplement Powder
1. Improves oxidation-related degenerative diseases and physical dysfunction
NMN Supplement Powder for Alzheimer's disease: The incidence of Alzheimer's disease (AD) is increasing every year with the accelerating trend of an ageing society. The disease is a central nervous system disorder characterised by cognitive impairment and memory damage. Abnormalities in mitochondrial structure and function are one of the factors in the pathogenesis of AD, and NMN Supplement Powder promotes energy metabolism in mitochondria, which has an important role in improving cognitive and memory functions. It was found that when the level of NMN Supplement Powder was increased in the body, NAD+ availability was then increased, which increased the mitochondrial oxygen consumption rate (OCR), promoted mitochondrial fusion and reduced the tendency of fission, resulting in the production of longer mitochondria in the hippocampal subregion, thus improving mitochondrial respiratory function.
2. NMN Supplement Powde for Parkinson's Disease: Parkinson's disease (PD) is characterised by motor symptoms such as bradykinesia, resting tremor, tonicity, abnormal gait and posture, and non-motor symptoms such as hyposmia, anxiety and depression, and constipation. It is a degenerative disease of the central nervous system that occurs in the elderly. The pathogenesis of the disease is complex and still unknown, so there is little effective treatment available. Studies have shown that NMN Supplement Powde improves neuronal cell survival, reduces apoptosis, restores NAD+ and ATP levels, inhibits apoptosis, counteracts energy damage and improves mitochondrial inhibitor-induced impairment of energy metabolism. Compared to Alzheimer's disease, the effects of β-Nicotinamide Mononucleotide on Parkinson's disease are less well studied and more in vivo experimental data are needed to prove its effectiveness.
Certiicate of Analysis
Product Name: | β- Nicotinamide Mononucleotide ( β-NMN) | Country of Origin: | China |
Molecular Formula: | C11H15N2O8P | CAS No: | 1094-61-7 |
Batch Number: | LEN-20220301 | Manufacture Date: | Mar 1st, 2022 |
Quantity | 220KGS | Expiry Date: | Feb 28th,2024 |
ITEM | SPECIFICATION | RESULTS | METHODS |
Appearance | Pure White fine particle | Complies | Organoleptic |
Odor | Characteristic | Complies | Organoleptic |
Clarity( 1g/ 100ml water) | Rapid solubility to produce crystal clear, colorless liquid | Complies | Organoleptic |
Particle Size | 100% pass 40 Mesh sieve | Complies | CP2020 |
Bulk Density | Report data | 0.33g/ml | GB18798.5 |
Tap Density | Report data | 0.45g/ml | GB18798.5 |
Purity (area%) | ≥99.0 | 99.90% | HPLC |
β - nicotinamide mononucleotide( w/ w% ) |
≥99.0 | 99.50% | HPLC |
Total Impurities | ≤ 0.4 | 0.10% | HPLC |
Loss on drying(%) | ≤ 1.0 | 0.30 | GB5009.3 |
PH( 1mg/ 1ml water) | 2.0-4.0 | 3.1 | GB9724 |
Heavy metals | |||
Heavy Metals(ppm) | ≤ 10 | <10 | CP2020 |
Arsenic(ppm) | ≤0.5 | Complies | CP2020 |
Mercury(ppm) | ≤0. 1 | Complies | CP2020 |
Lead(ppm) | ≤0.5 | Complies | CP2020 |
Cadmium(ppm) | ≤0. 1 | Complies | CP2020 |
Residual solvent | |||
Residual solvent Methanol(ppm) |
|
|
|
Ethanol(ppm) | ≤5000 | 65 | GC |
Ethyl acetate(ppm) | ≤5000 | N.D | GC |
Trimethyl phosphate( ppm) |
≤400 | N.D | GC |
Microbiological | |||
Total Plate Count(cfu/g) | ≤1000 | <10 | CP2020 |
Yeast & Mold(cfu/g) | ≤100 | <10 | CP2020 |
Coliform(MPN/g) | ≤3 | N.D | CP2020 |
E.Coli (/10g) | Negative | Negative | CP2020 |
Salmonella(/25g) | Negative | Negative | CP2020 |
Storage | Store in a well- closed container away from moisture, light and oxygen. |
Application of NMN Supplement Powder in Medical Care
Given the biological activity of NMN Supplement Powder described above, the development of drugs with NMN as the active ingredient has become a medical hotspot. Huizenga in the USA invented a group of compositions containing active ingredients such as NAD+, NMN and NR for anti-ageing and antioxidant therapy. Akihiro et al. at Yoshida University invented NMN and NR and their salts as raw materials for the treatment of corneal disorders. Imai at the University of Washington has developed treatments for age-related obesity, hyperlipidaemia, type 2 diabetes and drugs with NMN as the active ingredient Douglas et al. have invented methods for the assessment and treatment of vascular endothelial disorders and drugs with NMN as the active ingredient Michael et al. have developed NMN modulators (a neuroprotective drug) for the treatment of neurodegenerative diseases.
Enter Your Message